3-(4-Chlorophenyl)-5-phenyl-4-(p-tolyl)-4H-1,2,4-triazole

Catalog No.: 
ACYATQ123
CAS No.: 
332910-20-0
Molecular Formula: 
C21H16ClN3
Molecular Weight: 
345.83
3-(4-Chlorophenyl)-5-phenyl-4-(p-tolyl)-4H-1,2,4-triazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$90.00InquiryInquiry
1g97%$272.00InquiryInquiry
5g97%$1346.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(4-Chlorophenyl)-5-phenyl-4-(p-tolyl)-4H-1,2,4-triazole
IUPAC Name3-(4-chlorophenyl)-5-phenyl-4-(p-tolyl)-4H-1,2,4-triazole
MDL No.MFCD02738384
Molecular FormulaC21H16ClN3
Molecular Weight345.83
SMILESCC1=CC=C(N2C(C3=CC=C(Cl)C=C3)=NN=C2C4=CC=CC=C4)C=C1
InChI KeyVCEQUSSLRDAGJD-UHFFFAOYSA-N
Synonym3-(4-chlorophenyl)-4-(4-methylphenyl)-5-phenyl-4H-1,2,4-triazole
CAS No.332910-20-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACYATQ123 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACHZRV039 route compound structure diagram
    ACHZRV0391679-18-1In Stock
  4. Then
  5. ACYATQ123 route product structure diagram
    ACYATQ123332910-20-0
Inquiry

2. ACYATQ123 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACHZRV039 route compound structure diagram
    ACHZRV0391679-18-1In Stock
  4. Then
  5. ACYATQ123 route product structure diagram
    ACYATQ123332910-20-0
Inquiry

3. ACYATQ123 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYATQ123 route product structure diagram
    ACYATQ123332910-20-0
Inquiry

Comments (0)